Last Updated on September 28, 2024 by The Health Master

NPPA

Download NPPA notification No. S.O. 3867 (E) dt 10-09-2024, the link is given below: The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 62 formulations under the Drugs (Prices Control) Order, 2013, vide S.O. 3867(E) dt 10-09-2024 based on the decision of 126th Authority meeting dated 09-09-2024.

The notification states as follows:

In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;

A table is given below the article

Note:

(a) The manufacturer of the above-mentioned formulations, i.e., the “new drug” under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.

(b) The manufacturer may add Goods and Services Tax only if they have actually paid it or it is payable to the Government on the retail price mentioned in column (6) of the above-mentioned table.

(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013.

The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above, i.e., those who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to the fulfillment of all the applicable statutory requirements as laid down by the government under relevant statutes or rules,
including manufacturing license permission from the competent authority, i.e., the central or state licensing authority, as may be applicable, by the concerned manufacturer/marketing company.

(f) In case the retail price of any of the aforesaid formulations is not complied with, as per the instant price notification and notes specified hereinabove, then the concerned manufacturer / marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.

(g) Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with the strength and name of the manufacturer and marketing company specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer and marketing company
Companies as specified in corresponding entries in Columns (2), (3), and (5) thereof, if any, issued prior to this notification, stand superseded.

Table

S. No.	Medicines	Strength	Unit	Manufacturer & Marketing Company	Retail Price (in Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
1	Ibuprofen & Paracetamol Suspension	Each 5ml contains: Ibuprofen IP 100 mg, Paracetamol IP 162.5mg	1 ml	M/s Innova Captab Ltd/ M/s Dr. Reddy’s Laboratories Ltd	0.50
2	Telmisartan, Amlodipine & Hydrochlorothiazide tablets	Each film coated tablet contains: Telmisartan IP 40mg, Amlodipine Besilate IP eq to Amlodipine 5mg, Hydrochlorothiazide IP 12.5mg	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd/ M/s Sun Pharmaceutical Industries Ltd	10.23
3	Telmisartan, Cilnidipine & Chlorthalidone tablets	Each film coated tablet contains: Telmisartan IP 40mg, Cilnidipine IP 10mg, Chlorthalidone IP 12.5mg	1 Tablet	M/s Pure & Cure Healthcare Pvt. Ltd. / M/s Abbott Healthcare Pvt. Ltd.	14.73
4	Telmisartan, Chlorthalidone & Amlodipine tablets	Each film coated tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 6.25mg, Amlodipine Besylate IP eq. to Amlodipine 5mg	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Eris Lifesciences Limited	10.65
5	Telmisartan, Cilnidipine & Chlorthalidone Tablets	Each film coated bilayered tablet contains: Telmisartan IP 40mg, Cilnidipine IP 10mg, Chlorthalidone IP 12.5 mg	1 Tablet	M/s Windlas Biotech Ltd. / M/s Emcure Pharmaceuticals Limited	14.85
6	Amlodipine, Telmisartan and Metoprolol Succinate (Extended Release) tablets	Each film coated bilayered tablet contains: Metoprolol Succinate IP 47.5 mg eq. to Metoprolol Tartrate 50mg (as extended release form), Telmisartan IP 40mg, Amlodipine Besylate IP eq. to Amlodipine 5mg	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Cipla Limited	13.20
7	Amlodipine, Telmisartan and Metoprolol Succinate (Extended Release) tablets	Each film coated bilayered tablet contains: Metoprolol Succinate IP 47.5 mg eq. to Metoprolol Tartrate 50mg (as extended release form), Telmisartan IP 40mg, Amlodipine Besylate IP eq. to Amlodipine 5mg	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Akumentis Healthcare Ltd.	13.20
8	Metoprolol Succinate (ER), Cilnidipine & Telmisartan tablets	Each film coated bilayer tablet contains: Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate 25mg (As Extended release from), Cilnidipine IP 10mg, Telmisartan IP 40mg	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s USV Private Limited	9.82
9	Metoprolol Succinate (ER), Cilnidipine & Telmisartan Tablets	Each film coated bilayer tablet contains: Metoprolol Succinate IP 47.5mg eq. to Metoprolol Tartrate 50mg (As Extended release from), Cilnidipine IP 10mg, Telmisartan IP 40mg	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s USV Private Limited	12.50
10	Bisoprolol Fumarate and Telmisartan Tablets	Each film coated tablet contains: Bisoprolol Fumarate IP 5 mg, Telmisartan IP 40 mg	1 Tablet	M/s Akums Drugs and Pharmaceuticals Ltd. / M/s Abbott Healthcare Pvt. Ltd.	11.21

11	Bisoprolol Fumarate and Telmisartan Tablets	Each film coated tablet contains: Bisoprolol Fumarate IP 2.5 mg, Telmisartan IP 40 mg	1 Tablet	M/s Akums Drugs and Pharmaceuticals Ltd. / M/s Abbott Healthcare Pvt. Ltd.	9.65
12	Bisoprolol Fumarate and Telmisartan Tablets	Each film coated tablet contains: Bisoprolol Fumarate IP 2.5 mg, Telmisartan IP 40 mg	1 Tablet	M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Cipla Limited	9.65
13	Bisoprolol Fumarate and Telmisartan Tablets	Each film coated tablet contains: Bisoprolol Fumarate IP 5 mg, Telmisartan IP 40 mg	1 Tablet	M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Cipla Limited	11.21
14	Bisoprolol Fumarate and Telmisartan Tablets	Each film coated tablet contains: Bisoprolol Fumarate IP 2.5 mg, Telmisartan IP 40 mg	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Medley Pharmaceuticals Ltd.	9.65
15	Bisoprolol Fumarate and Telmisartan Tablets	Each film coated tablet contains: Bisoprolol Fumarate IP 5 mg, Telmisartan IP 40 mg	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Medley Pharmaceuticals Ltd.	11.21
16	Levofloxacin Infusion IP	Each 100ml Contains: Levofloxacin Hemihydrate IP eq to Levofloxacin 500mg, Sodium Chloride IP 900 mg	1 ml	M/s Pure and Cure Healthcare Pvt Ltd/ M/s Dr Reddy’s Laboratories Ltd	1.51
17	Moxifloxacin Eye drops IP	Composition: Moxifloxacin Hydrochloride IP eq. to Moxifloxacin 0.5% w/v	1 ml	M/s Appasamy Ocular Devices Pvt. Ltd. / M/s Mankind Prime Labs Pvt. Ltd.	27.00
18	Moxifloxacin & Ketorolac Tromethamine Eye drops IP	Composition: Moxifloxacin Hydrochloride IP eq. to Moxifloxacin 0.5% w/v Ketorolac Tromethamine IP 0.4% w/v Benzalkoniumchloride Solution 0.01%v/v (as preservative)	1 ml	M/s Appasamy Ocular Devices Pvt. Ltd. / M/s Mankind Prime Labs Pvt. Ltd.	25.32
19	Moxifloxacin & Dexamethasone Eye drops	Composition: Moxifloxacin Hydrochloride IP eq. to Moxifloxacin 0.5% w/v, Dexamethasone Sodium Phosphate IP eq. to Dexamethasone Phosphate 0.1%w/v	1 ml	M/s Appasamy Ocular Devices Pvt. Ltd. / M/s Mankind Prime Labs Pvt. Ltd.	25.04
20	Ofloxacin & Dexamethasone Sodium Phosphate Ophthalmic Solution	Composition: Ofloxacin IP 0.3% w/v, Dexamethasone Sodium Phosphate IP eq. to Dexamethasone Phosphate 0.1%w/v, Benzalkonium Chloride Solution IP 0.02%w/v (as preservative)	1 ml	M/s Hanuchem Laboratories / M/s Mankind Prime Labs Pvt. Ltd.	5.24

21	Chloramphenicol & Dexamethasone Sodium Phosphate Eye/Ear drops	Composition: Chloramphenicol IP 1%w/v, Dexamethasone Sodium Phosphate IP 0.1%w/v, Phenyl Mercuric Nitrate Ip 0.002%w/v (as preservative)	1 ml	M/s Hanuchem Laboratories / M/s Mankind Prime Labs Pvt. Ltd.	5.88
22	Tobramycin & Dexamethasone Ophthalmic Solution	Composition: Tobramycin Sulfate USP eq to Tobramycin 0.3%w/v, Dexamethasone Sodium Phosphate IP eq to Dexamethasone Phosphate 0.1%w/v, Benzalkonium Chloride Solution IP 0.02%v/v (as preservative)	1 ml	M/s Hanuchem Laboratories / M/s Mankind Prime Labs Pvt. Ltd.	5.78
23	Aceclofenac, Paracetamol & Serratiopeptidase Tablets	Each film coated tablet contains: Aceclofenac IP 100mg, Paracetamol IP 325mg, Serratiopeptidase IP 15mg (As enteric coated tablet eq. to enzyme activity 30000 units)	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Abbott Healthcare Pvt. Ltd.	9.74
24	Mefenamic Acid and Paracetamol Tablets	Each uncoated tablet contains: Mefenamic Acid IP 250mg Paracetamol IP 325mg	1 Tablet	M/s Blue Cross Laboratories Pvt. Ltd.	3.82
25	Paracetamol and Mefenamic Acid suspension	Each 5ml contains: Mefenamic Acid 100mg, Paracetamol IP 250mg	1 ml	M/s Windlas Biotech Limited / M/s Biological E. Limited	0.90
26	Diclofenac Sodium Injection IP	Each ml contains: Diclofenac Sodium IP 75mg	1 ml	M/s Fast Pharma Pvt. Ltd. / M/s Cadila Pharmaceuticals Ltd.	28.70
27	Lactulose Enema 20% w/v	Each ml contains: Lactulose Concentrate USP eq. to Lactulose 200mg, Benzyl Alcohol IP 3mg	1 ml	M/s Merril Pharma Private Ltd. / M/s Alkem Laboratories Ltd.	1.19
28	Cefadroxil and Clavulanic Acid dispersible Tablets	Each uncoated dispersible tablet contains: Cefadroxil Monohydrate IP eq. to Cefadroxil 250mg, Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 62.5mg	1 Tablet	M/s Twenty First Century Pharmaceuticals Pvt. Ltd. / M/s Indoco Remedies Limited	9.30
29	Cefadroxil and Clavulanic Acid Tablets	Each film coated tablet contains: Cefadroxil Monohydrate IP eq. to Cefadroxil 500mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125mg	1 Tablet	M/s Twenty First Century Pharmaceuticals Pvt. Ltd. / M/s Indoco Remedies Limited	17.61
30	Ferrous Ascorbate and Folic Acid Suspension IP	Each 5ml contains: Ferrous Ascorbate IP eq. to Elemental Iron 30mg Folic Acid IP 550mcg	1 ml	M/s Tirupati Medicare Ltd. / M/s Intas Pharmaceuticals Ltd.	0.95

31	Combi pack of Clarithromycin Tablets IP, Esomeprazole Tablets IP & Amoxicillin Tablets USP	Each Strip contains: Clarithromycin Tablets IP 2 Tablets Each film coated tablet contains: Clarithromycin IP 500mg Esomeprazole Tablets IP 2 Tablets Each Enteric coated tablet contains: Esomeprazole Magnesium Trihydrate IP eq. to Esomeprazole 40mg Amoxicillin Tablets USP 2 Tablets Each Film coated tablet contains: Amoxycillin Trihydrate IP eq. to Amoxycillin 750mg	Combi kit pack	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Mankind Pharma Limited	166.74
32	Etoricoxib and Paracetamol Tablets	Each Film Coated tablet contains: Etoricoxib IP 60 mg (As Micronized), Paracetamol IP 325 mg	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Pharmed Limited	9.15
33	Etoricoxib and Paracetamol Tablets	Each film coated Tablet contains: Etoricoxib IP 60mg (As micronized) Paracetamol IP 325mg	1 Tablet	M/s Synokem Lifesciences Pvt. Ltd. / M/s Cipla Ltd.	9.15
34	Levosalbutamol & Ipratropium Bromide respirator solution	Each 2.5 ml contains: Levosalbutamol Sulphate eq. to Levosalbutamol 1.25 mg + Ipratropium Bromide eq. to Ipratropium (Anhydrous) 500 mcg	1 ml	M/s Axa Parenterals Limited / M/s Workcell Solutions Private Limited	5.75
35	Povidone Iodine Gargle	Composition: Povidone-Iodine IP 2% w/v (Available Iodine 0.2% w/v) Ethanol 95% IP eq. to Absolute Alcohol 8.38% v/v	1 ml	M/s Pontika Aerotech Limited / M/s Abbott Healthcare Pvt. Ltd.	1.96
36	Omeprazole & Domperidone Capsules IP	Each hard gelatin capsule contains: Omeprazole IP 20mg (as Enteric coated), Domperidone IP 10mg (As Instant release)	1 Capsule	M/s Hetero Healthcare Ltd.	6.28
37	Tolperisone Hydrochloride and Paracetamol Tablets	Each film coated tablet contains: Tolperisone Hydrochloride IP 150mg, Paracetamol IP 325mg	1 Tablet	M/s Pure and cure Healthcare Pvt. Ltd. / M/s Intas Pharmaceuticals Ltd.	13.95
38	Escitalopram Tablets	Each film coated tablet contains: Escitalopram Oxalate IP eq. to Escitalopram 15mg	1 Tablet	M/s East African (India) Overseas / M/s Torrent Pharmaceuticals Ltd.	13.00
39	Escitalopram Oxalate + Clonazepam Tablets	Each film coated tablet contains: Escitalopram Oxalate IP eq. to Escitalopram 5mg, Clonazepam IP 0.25mg	1 Tablet	M/s East African (India) Overseas / M/s Torrent Pharmaceuticals Ltd.	7.74
40	Escitalopram Oxalate + Clonazepam Tablets	Each film coated tablet contains: Escitalopram Oxalate IP eq. to Escitalopram 20mg, Clonazepam IP 0.5mg	1 Tablet	M/s East African (India) Overseas / M/s Torrent Pharmaceuticals Ltd.	19.67

41	Atorvastatin and Aspirin Capsules	Each hard gelatin capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 10mg, Aspirin IP 150mg (As two enteric coated tablet USP 75mg)	1 Capsule	M/s Unison Pharmaceuticals Pvt. Ltd.	2.54
42	Riboflavin, Folic Acid Niacinamide & Lactic Acid Bacillus Tablets	Each uncoated tablet contains: Riboflavin IP 10mg, Folic Acid IP 1.5mg, Niacinamide IP 100mg, Lactic Acid Bacillus 60Million Spores	1 Tablet	M/s Prosperity Drugs Pvt. Ltd. / M/s Intas Pharmaceuticals Ltd.	4.11
43	Empagliflozin and Metformin Hydrochloride Tablets	Each film coated tablet contains: Empagliflozin 5mg, Metformin Hydrochloride IP 500mg	1 Tablet	M/s Mankind Pharma Limited	15.84
44	Empagliflozin and Metformin Hydrochloride Tablets	Each film coated tablet contains: Empagliflozin 12.5 mg, Metformin Hydrochloride IP 1000mg	1 Tablet	M/s Mankind Pharma Limited	19.01
45	Empagliflozin and Metformin Hydrochloride Tablets	Each film coated tablet contains: Empagliflozin 12.5 mg, Metformin Hydrochloride IP 500mg	1 Tablet	M/s Mankind Pharma Limited	18.10
46	Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablets	Each film coated Bilayered Tablet Contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg, Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg, Metformin Hydrochloride IP 1000mg (as Sustained Release Form)	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Aristo Pharmaceuticals Pvt. Ltd.	15.32
47	Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablets	Each film coated Bilayered Tablet Contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg, Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg, Metformin Hydrochloride IP 500mg (as Sustained Release Form)	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Sun Pharma Laboratories Limited	14.00
48	Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablets	Each film coated Bilayered Tablet Contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg, Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg, Metformin Hydrochloride IP 1000mg (as Sustained Release Form)	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Sun Pharma Laboratories Limited	15.32
49	Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablets	Each film coated Bilayered Tablet Contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg, Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg, Metformin Hydrochloride IP 500mg (as Sustained Release Form)	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Micro Labs Limited	14.00
50	Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablets	Each film coated Bilayered Tablet Contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg, Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg, Metformin Hydrochloride IP 1000mg (as Sustained Release Form)	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Micro Labs Limited	15.32

51	Sitagliptin, Metformin Hydrochloride and Glimepiride Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg, Metformin Hydrochloride IP 1000mg, Glimepiride IP 1 mg	1 Tablet	M/s Synokem Pharmaceuticals Ltd. / M/s Apex Laboratories Private Limited	11.60
52	Sitagliptin, Metformin Hydrochloride and Glimepiride Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg, Metformin Hydrochloride IP 1000mg, Glimepiride IP 2 mg	1 Tablet	M/s Synokem Pharmaceuticals Ltd. / M/s Apex Laboratories Private Limited	11.60
53	Linagliptin, Dapagliflozin & Metformin Hydrochloride (SR) Tablets	Each film coated bilayer Tablet contains: Linagliptin 5mg, Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg, Metformin Hydrochloride IP 1000mg (as sustained release form)	1 Tablet	M/s Theon Pharmaceuticals Ltd. / M/s Emcure Pharmaceuticals Ltd.	20.33
54	Linagliptin, Dapagliflozin & Metformin Hydrochloride (SR) Tablets	Each film coated bilayer Tablet contains: Linagliptin 5mg, Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg, Metformin Hydrochloride IP 500mg (as sustained release form)	1 Tablet	M/s Theon Pharmaceuticals Ltd. / M/s Emcure Pharmaceuticals Ltd.	18.92
55	Dapagliflozin, Vildagliptin (SR) and Metformin Hydrochloride (SR) tablets	Each film coated bilayered tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg, Vildagliptin IP 100mg (as sustained release), Metformin Hydrochloride IP 1000mg (as sustained release)	1 Tablet	M/s Synokem Pharmaceuticals Ltd. / M/s Blue Cross Laboratories Pvt. Ltd.	11.70
56	Empagliflozin + Metformin Hydrochloride Tablets	Each film coated tablet contains: Empagliflozin 5mg Metformin Hydrochloride IP 850mg	1 Tablet	M/s Mankind Pharma Limited	11.51
57	Empagliflozin+ Metformin Hydrochloride Tablets	Each film coated tablet contains: Empagliflozin 5mg Metformin Hydrochloride IP 1000mg	1 Tablet	M/s Mankind Pharma Limited	11.38
58	Empagliflozin+ Metformin Hydrochloride Tablets	Each film coated tablet contains: Empagliflozin 12.5mg Metformin Hydrochloride IP 850mg	1 Tablet	M/s Mankind Pharma Limited	17.24
59	Calcium carbonate + Magnesium Hydroxide + Zinc Sulphate + Vitamin D3 tablets	Each film coated tablet contains: Magnesium Hydroxide IP eq. to Elemental Magnesium 50mg, Vitamin D3 IP 1000IU, Zinc Sulphate Monohydrate IP eq. to Elemental Zinc 10mg, Calcium Carbonate IP eq. to Elemental Calcium 500mg	1 Tablet	M/s Unison Pharmaceuticals Pvt. Ltd.	10.00
60	Dapagliflozin + Metoprolol tablets	Each film coated bilayered Tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg, Metoprolol Succinate IP 47.5mg eq. to Metoprolol Tartrate 50mg (as Sustained release)	1 Tablet	M/s ERIS Lifesciences Limited	16.77

61	Montelukast + Bilastine tablets	Each film coated tablet contains: Montelukast Sodium IP Eq. to Montelukast 10mg, Bilastine IP 40mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Sun Pharma Laboratories Limited	28.76
62	Montelukast + Bilastine tablets	Each film coated tablet contains: Montelukast Sodium IP Eq. to Montelukast 10mg, Bilastine IP 40mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Sun Pharmaceutical Industries Limited	28.76

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

For informative videos by The Health Master, click on the below YouTube icon:

• Key Notes on Revised Schedule M: Point No. 14 – Materials
  December 25, 2024
• USFDA issues VAI status to Biocon for Bengaluru API facility
  December 25, 2024
• Bulk drug import from China continues to rise in 5 years
  December 25, 2024
• High Court stays action against Pharma Units manufacturing Nutraceuticals
  December 25, 2024
• NPPA fixed retail price of 7 formulations: December 2024
  December 24, 2024
• Revised Schedule M: Industry seeks balance between Quality and Viability
  December 24, 2024

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

For informative videos on consumer awareness, click on the below YouTube icon: